Germline mutations were identified in three cases: 2/48 cases with breast (4.2%) and 1/19 cases with ovarian (5.3%) cancer carried pathogenic deleterious germline mutations in the BRCA2 gene. The gene discussed is BRCA2; the disease is cancer.